One of the more difficult decisions for patients with poorly controlled type 2 diabetes, as well as for their clinicians, is when to add or switch to daily insulin therapy. Initiation of longer-acting ...

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial weight loss in adults with type 1 diabetes who ...

Novo Nordisk A/S’s once-weekly diabetes drug was recommended for approval in the European Union, paving the way for patients ...

Weight loss can be effective in managing type 2 diabetes, a condition where a person cannot control their blood glucose levels. However, losing weight can be challenging, so finding a method of weight ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found. In QWINT-1, there was a similar ...

This open-label, 40-week, phase 3 trial assessed the efficacy and safety of tirzepatide, a weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist under ...

Eating fries three times a week raises the risk of diabetes by 20%, warns new research. But scoffing similar amounts of boiled, baked or mashed potatoes is not associated with such a "substantial" ...

Researchers have found that consuming more servings of french fries can be tied to an increased risk of Type 2 diabetes According to a study published in the British Medical Journal, eating three or ...